Emerging Opportunities in Immunoassay Testing Technologies
Valued at USD 34.46 billion in 2025, the Immunoassay Market is projected to reach USD 36.03 billion in 2026 and USD 50.95 billion by 2034, growing at a CAGR of 4.4% during the forecast period 2026–2034. Key players include Abbott, BD, Beckman Coulter, Inc., bioMérieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, QuidelOrtho Corporation, Siemens Healthineers AG, Sysmex Corporation, and Thermo Fisher Scientific Inc. Growth is driven by the prevalence of chronic and infectious diseases, technological advancements, and the development of healthcare infrastructure.
Detection and Quantification Across Clinical and Research Settings
The immunoassay industry enables the detection and quantification of antibodies, antigens, hormones, proteins, and other important biomarkers. For B2B stakeholders, the Immunoassay Market spans clinical diagnostics, disease screening, pharmaceutical development, and therapeutic monitoring, supported by rising demand for early disease detection and accurate results.
Reagents and Kits Lead Product Demand
In 2025, the reagents and kits segment maintained its leading position, owing to the rising number of chronic and infectious disease cases. Hospitals and laboratories value kits for ease of handling, standard methodologies, and high sensitivity and accuracy. ELISA immunoassay kits are in particular demand for accuracy, reliability, and economy, and their compatibility with automated systems supports frequent use. BD Life Sciences offers ELISA kits that identify specific biomarkers, noted for high sensitivity and specificity.
Sensitivity, Throughput, and Automation
Chronic disease management increasingly depends on high-sensitivity immunoassay testing, which helps determine appropriate marker levels. Advances such as high-throughput systems, multiplex testing, and automation are improving testing speed and efficiency. These solutions help large diagnostic laboratories manage high sample volumes while reducing turnaround time and operating costs. Label-free, rapid, and high-throughput platforms, including surface plasmon resonance, offer faster, more accurate, and more affordable diagnosis. Immunoassay kits are also being transformed by multiplex, smartphone-enabled, and point-of-care immunoassays, which provide fast, convenient testing.
Read More @ https://www.polarismarketresearch.com/industry-analysis/immunoassay-market
Precision Diagnostics Expand Specialty Demand
Growing preference for personalized medicine in oncology and cardiology is expanding the need for specialized tests and tailored treatments. In cancer care, an immunoassay measures protein levels to determine disease stage, while in autoimmune disease it measures antibody levels to monitor treatment progress. In December 2024, BIO-TECHNE launched its ESR1 Mutation Monitoring Assay, which detects mutations in patients with hormone receptor-positive metastatic breast cancer, illustrating how personalized medicine is pulling demand for precision diagnostics in North America.
Regional Outlook
North America accounted for the largest share of the Immunoassay Market in 2025, supported by high chronic and infectious disease incidence and developments in high-sensitivity assays, multiplexing, and automated platforms. Asia Pacific is expected to grow at the highest rate during the forecast period, driven by rising healthcare spending, a growing chronic disease burden, and an aging population. The WHO projects that the Southeast Asian population aged 60 and over will rise from 9.8% in 2017 to 13.7% in 2030 and 20.3% in 2050.
Competitive Landscape
Players invest in innovation to broaden product lines, yet face rising healthcare costs, stringent regulations, and competition from alternative diagnostic techniques. In January 2025, Anbio Biotechnology launched its ADL-1000 solution to deliver economical diagnostic results across clinical settings.
More Trending Latest Reports By Polaris Market Research:
top-data-center-interconnect-market-leaders-to-watch
process-mining-software-market
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Games
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Other
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness